Provider
QP85-23 MHCP Pharmacy Benefit Exclusion for Beyfortus™, Daxxify®, Elrexfio™, Izervay™, Talvey™, and Veopoz™
Program effective Date: Oct 11, 2023
Documents & Forms Results
Displaying 1601 - 1610 of 3165 results
Provider
QP86-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective November 1, 2023
Program effective Date: Oct 11, 2023
Provider
QP87-23 Availity Essentials Updated Claim Entry Forms
Program effective Date: Oct 11, 2023
Provider
QP80-23 Blue Cross Response to Medical Oncology Drug Shortage of Cisplatin and Carboplatin
Program effective Date: Oct 11, 2023
Provider
QP81-23 Update: Medical Drug Update for Tofersen (Qalsody), Delandistrogene Moxeparvovec (Elevidys), and Donislecel (Lantidra)
Program effective Date: Oct 11, 2023
Provider
QP82-23 Commercial Pharmacy Benefit Exclusion for Beyfortus™, Daxxify®, Izervay™, and Veopoz™
Program effective Date: Oct 11, 2023
Provider
QP83-23 Commercial Pharmacy Benefit Exclusion for Budesonide-Formoterol Aerosol Inhaler and Tiotropium Bromide Inhalation Capsule
Program effective Date: Oct 11, 2023
Provider
QP84-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective December 1, 2023
Program effective Date: Oct 11, 2023
Provider
QP55R1-23 Change in Processing for Replacement Claims
Program effective Date: Oct 11, 2023